http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110882473-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-0238 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2207-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-105 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1029 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-10 |
| filingDate | 2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110882473-B |
| titleOfInvention | Medicinal balloon catheter and preparation method thereof |
| abstract | The invention discloses a medicine balloon catheter, and belongs to the field of medical instruments and advanced manufacturing. A drug balloon catheter comprising a balloon and at least one drug coating covering the surface of the balloon; the drug coating is divided into a low drug content coating and a high drug content coating, wherein the high drug content coating is composed of an active drug or the active drug and a carrier, and the low drug content coating is composed of the active drug and the carrier. The invention has the following advantages: the medicine balloon catheter with the coatings with different medicine contents provided by the invention can effectively reduce the medicine loss of the medicine balloon in the conveying process in the operation, reduce the medicine loss of the outermost layer and the far end of the balloon, reduce the medicine residue on the surface and the near end of the balloon in the withdrawing process of the medicine balloon after the operation, and reduce the medicine damage to the non-target lesion part. |
| priorityDate | 2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.